|
Duloxetine
Theoretical analysis:Duloxetine
MF: C18H19NOS
MW: 297.41
CAS: 116539-59-4
Availability and price:Duloxetine
More>>
|
|
|
Fidarestat
Theoretical analysis:Fidarestat
MF: C12H10FN3O4
MW: 279.22
CAS: 136087-85-9
Availability and price:FidarestatMore>>
|
|
|
Darbufelone
Theoretical analysis:Darbufelone
MF: C18H24N2O2S
MW: 332.46036
CAS: 139226-28-1
Availability and price:Darbufelo...
More>>
|
|
|
Ethirimol
Theoretical analysis:Ethirimol
MF: C11H19N3O
MW: 209.29
CAS: 23947-60-6
Availability and price:Ethirimol
...
More>>
|
|
|
Retigabine
Theoretical analysis:Retigabine
MF: C16H18FN3O2
MW: 303.3314232
CAS: 150812-12-7
Availability and price:Retigabi...
More>>
|
|
|
Tiletamine
Theoretical analysis:Tiletamine
MF: C12H17NOS
CAS: 14176-49-9
Availability and price:Tiletamine
Pakag...
More>>
|
|
|
LY2940680
Description of:LY2940680
M.Wt: 512.5
Formula: C26H24F4N6O
Solubility: Unknown
Purity: 98%
Storage: at -20℃ 2 years<...
More>>
|
|
|
LY2886721
Description of:LY2886721
LY2886721 is a novel potent agent that is used to treat Alzheimer’s Disease in preclinical experiments. More>>
|
|
|
CPI-613
Description of:CPI-613
CPI-613 is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lipoic acid analogue with potential ch...
More>>
|
|
|
LX1606
Description of:LX1606
LX1606 is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibitor prodrug with potential ant...
More>>
|
|